军人创伤后应激障碍和轻度创伤性脑损伤共病诊治的研究进展

Research progress in diagnosis and treatment of mild traumatic brain injury and posttraumatic stress disorder comorbidity in the soldiers

创伤后应激障碍(PTSD)和轻度创伤性脑损伤(mTBI)是现代战争的标志性损伤,美军和英军的共病率分别为23%和33%~66%。目前缺乏对PTSD和mTBI的早期诊断方法,也无特效治疗方法和药物,从而严重影响部队战斗力。笔者从PTSD和mTBI的发生率、共病率、临床表现、诊断方法及治疗方法等方面总结临床和基础研究进展,为军人PTSD和mTBI的诊治提供参考。

Posttraumatic stress disorder(PTSD)and mild traumatic brain injury(mTBI)are the signature injuries of modern war.The comorbidity rate of PTSD and mTBI in American and British soldiers is 23%and 33%36%,respectively.At present,there is no early diagnosis methods,specific treatment methods or drugs,which seriously affects the combat effectiveness of the army.The authors summarize the clinical and basic researches in recent years from incidence,comorbidity,clinical manifestations,diagnostic and treatment methods in an attempt to offer a reference for the treatment of PTSD and mTBI in soldiers.